| __timestamp | Novo Nordisk A/S | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 74244000000 | 11503000 |
| Thursday, January 1, 2015 | 91739000000 | 24698000 |
| Friday, January 1, 2016 | 94597000000 | 26076000 |
| Sunday, January 1, 2017 | 94064000000 | 33570000 |
| Monday, January 1, 2018 | 94214000000 | 58697000 |
| Tuesday, January 1, 2019 | 101933000000 | 80279000 |
| Wednesday, January 1, 2020 | 106014000000 | 84228000 |
| Friday, January 1, 2021 | 117142000000 | 106025000 |
| Saturday, January 1, 2022 | 148506000000 | 109788000 |
| Sunday, January 1, 2023 | 196496000000 | 135576000 |
| Monday, January 1, 2024 | 245881000000 |
Unleashing insights
In the world of pharmaceuticals and biotechnology, the race for higher gross profits is fierce. Over the past decade, Novo Nordisk A/S, a Danish multinational, has consistently outperformed its American counterpart, Vericel Corporation, in terms of gross profit. From 2014 to 2023, Novo Nordisk's gross profit surged by over 160%, reaching a staggering $196 billion in 2023. In contrast, Vericel Corporation, while showing growth, achieved a gross profit of approximately $136 million in the same year.
This stark difference highlights Novo Nordisk's dominance in the industry, with its gross profit being over 1,400 times that of Vericel in 2023. The data underscores the importance of scale and market reach in achieving financial success. As the industry evolves, these figures serve as a benchmark for emerging companies aiming to make their mark.
Novo Nordisk A/S vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Novo Nordisk A/S and Evotec SE
Gross Profit Comparison: AstraZeneca PLC and Vericel Corporation Trends
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Vericel Corporation
Who Generates Higher Gross Profit? Genmab A/S or Vericel Corporation
Gross Profit Analysis: Comparing Incyte Corporation and Vericel Corporation
Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Vericel Corporation
Halozyme Therapeutics, Inc. vs Vericel Corporation: A Gross Profit Performance Breakdown
Pharming Group N.V. and Vericel Corporation: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: MorphoSys AG vs Vericel Corporation
Gross Profit Trends Compared: Vericel Corporation vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Vericel Corporation and Taro Pharmaceutical Industries Ltd.